Eczema
Eczema
Features
This visual 12-patient series by Drs Shumel and Rossi demonstrates the efficacy of dupilumab in patients aged 6 to 11 years with severe atopic dermatitis treated over a 16-week period.
News
Findings from a recent study showed dupilumab was safe and effective for treating treatment-resistant atopic dermatitis over a year in a real-world setting.
News
A recent review investigated the mechanisms, diagnosis, and management of infectious complications associated with atopic dermatitis, including the use of antibiotics.
News
Findings from a recent study suggest that topical calcineurin inhibitors are not associated with an increased risk of keratinocyte carcinomas among adult patients with atopic dermatitis.
Features
This visual 12-patient series by Drs Shumel and Rossi demonstrates the efficacy of dupilumab in patients aged 6 to 11 years with severe atopic dermatitis treated over a 16-week period.
